This website uses cookies. For more information please contact us or consult our privacy policy.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
- Home
- News and Insights
- Insights
- IRS Guidance on Reimbursements of Over the Counter Drugs and HHS Bulletin on Waiver Program for Annual Limits
IRS Guidance on Reimbursements of Over-the-Counter Drugs and HHS Bulletin on Waiver Program for Annual Limits
September 9, 2010, Covington Advisory
May 28, 2013
NEW YORK, May 28, 2013 — Omthera Pharmaceuticals and AstraZeneca announced today that the companies entered into a merger agreement under which AstraZeneca will acquire all of the outstanding stock of Omthera for an upfront payment of $12.70 in cash per share, approximately $323 million aggregate value ($260 million after subtracting cash), plus a contingent ...
Covington Announces Five New Counsel
April 1, 2011
WASHINGTON, DC, April 1, 2011 — Covington & Burling LLP is pleased to announce the promotion of two lawyers to of counsel and three lawyers to special counsel. The new of counsel are as follows: Alex Chinoy (Washington) focuses his practice on the resolution of international intellectual property disputes, with an emphasis on Section 337 unfair import ...
Covington Advises JLG Industries in $3.2 Billion Merger into Oshkosh Truck Corporation
10/16/2006
WASHINGTON, D.C., October 16, 2006 — The board of directors of JLG Industries, Inc. (NYSE: JLG) has approved an all cash offer of $28.00 per common share to merge with, and become, a subsidiary of Oshkosh Truck Corporation (NYSE: OSK). According to JLG’s press release, the $3.2 billion merger is dependent on the approval of JLG shareholders. The transaction is ...